Molecular monitoring of 8p11 myeloproliferative syndrome in an infant

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 11, 2009, Pages 879-883

  Zhang, Wenyong W ^a,b   Habeebu, Sultan ^a   Sheehan, Andrea M ^a   Naeem, Rizwan ^a   Hernandez, Vivian S ^a   Dreyer, Zoann E ^a   López Terrada, Dolores ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

EMS syndrome; Minimal disease monitoring; Molecular

Indexed keywords

ASPARAGINASE MACROGOL; CD2 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; DAUNORUBICIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; PREDNISONE; T6 ANTIGEN; VINCRISTINE;

ARTICLE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHROMOSOME 13Q; CHROMOSOME 8P; CHROMOSOME TRANSLOCATION; DISEASE SURVEILLANCE; EOSINOPHILIA; FEMALE; FUSION GENE; HUMAN; HUMAN TISSUE; INFANT; INFANT DISEASE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOBLASTOMA; MYELOPROLIFERATIVE DISORDER; PATIENT MONITORING; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 8; DNA-BINDING PROTEINS; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; MYELOPROLIFERATIVE DISORDERS; NEOPLASM, RESIDUAL; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS, FUSION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SYNDROME; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 74249117077     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181b83fd0     Document Type: Article

References (40)

1. Bain BJ, Gilliland DG, Horny HP, et al. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, or FGFR1. In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008:68-73.
2. Xiao S, Nalabolu SR, Aster JC, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet. 1998;18:84-87.
3. Smedley D, Hamoudi R, Clark J, et al. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Hum Mol Genet. 1998;7:637-642.
4. Popovici C, Adelaide J, Ollendorff V, et al. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12). Proc Natl Acad Sci USA. 1998;95:5712-5717.
5. Smedley D, Demiroglu A, Abdul-Rauf M, et al. ZNF198- FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5. Neoplasia. 1999;1:349-355.
6. Guasch G, Mack GJ, Popovici C, et al. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood. 2000; 95:1788-1796.
7. Belloni E, Trubia M, Gasparini P, et al. 8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes. Genes Chromosomes Cancer. 2005;42:320-325.
8. Walz C, Chase A, Schoch C, et al. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1. Leukemia. 2005;19:1005-1009.
9. Demiroglu A, Steer EJ, Heath C, et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood. 2001;98:3778-3783.
10. Grand EK, Grand FH, Chase AJ, et al. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer. 2004;40: 78-83.
11. Guasch G, Popovici C, Mugneret F, et al. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood. 2003;101:286-288.
12. Popovici C, Zhang B, Gregoire MJ, et al. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood. 1999;93:1381-1389.
13. Fioretos T, Panagopoulos I, Lassen C, et al. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Genes Chromosomes Cancer. 2001;32:302-310.
14. Goradia A, Bayerl M, Cornfield D. The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report. Int J Clin Exp Pathol. 2008;1:448-456.
15. Wong W-S, Cheng KC-K, Lau K-M, et al. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases. Leuk Res. 2007;31:235-238.
16. Kuskonmaz B, Kafali C, Akcoren Z, et al. The 8p11 myeloproliferative syndrome in a 3-year-old child. Leuk Res. 2008;32:198-199.
17. Vega F, Medeiros LJ, Davuluri R, et al. t(8;13)-positive bilineal lymphomas: report of 6 cases. Am J Surg Pathol. 2008; 32:14-20.
18. Abruzzo LV, Jaffe ES, Cotelingam JD, et al. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol. 1992;16:236-245.
19. Rao PH, Cesarman G, Coleman M, et al. Cytogenetic evidence for extramedullary blast crisis with t(8;13)(q11;p11) in chronic myelomonocytic leukemia. Acta Haematol. 1992; 88:201-203.
20. Fagan K, Hyde S, Harrison P. Translocation (8;13) and T-cell lymphoma. A case report. Cancer Genet Cytogenet. 1993;65: 71-73.
21. Leslie J, Barker T, Glancy M, et al. t(8;13) (p11;q12) translocation in a myeloproliferative disorder associated with a T-cell non-Hodgkin lymphoma. Br J Haematol. 1994;86: 876-878.
22. Macdonald D, Sheerin SM, Cross NC, et al. An atypical myeloproliferative disorder with t(8;13) (p11;q12): a third case. Br J Haematol. 1994;86:879-880.
23. Behringer D, Schaefer HE, Kunzmann R, et al. Translocation t(8;13) in a patient with T cell lymphoma and features of a myeloproliferative syndrome. Leukemia. 1995;9:988-992.
24. Inhorn RC, Aster JC, Roach SA, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/ malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity [see comments]. Blood. 1995;85:1881-1887.
25. Naeem R, Singer S, Fletcher JA. Translocation t(8;13) (p11;q11-12) in stem cell leukemia/lymphoma of T-cell and myeloid lineages. Genes Chromosomes Cancer. 1995;12: 148-151.
26. Michaux L, Mecucci C, Pereira Velloso ER, et al. About the t(8;13)(p11;q12) clinico-pathologic entity. Blood. 1996;87: 1658-1659.
27. Chernova O, Still I, Kalaycio M, et al. Characterization of the breakpoints in a t(8;13)(p11;q12) translocation from a patient with myeloproliferative disease using fluorescence in situ hybridization. Genes Chromosomes Cancer. 1998;21: 160-165.
28. Aguiar RC, Chase A, Coulthard S, et al. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood. 1997;90:3130-3135.
29. Somers GR, Slater H, Rockman S, et al. Coexistent T-cell lymphoblastic lymphoma and an atypical myeloproliferative disorder associated with t(8;13)(p21;q14). Pediatr Pathol Lab Med. 1997;17:141-158.
30. Still IH, Cowell JK. The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13. Blood. 1998;92:1456-1458.
31. Matsumoto K, Morita K, Takada S, et al. A chronic myelogenous leukemia-like myeloproliferative disorder accompanied by T-cell lymphoblastic lymphoma with chromosome translocation t(8;13)(p11;q12): a Japanese case. Int J Hematol. 1999;70:278-282.
32. Suzan F, Guasch G, Terre C, et al. Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). Br J Haematol. 2003;121:312-314.
33. Invernizzi R, Benatti C, Travaglino E, et al. A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12). Haematologica. 2004;89:239-241.
34. Reiter A, Sohal J, Kulkarni S, et al. Consistent Fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood. 1998;92: 1735-1742.
35. Macdonald D, Reiter A, Cross NC. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol. 2002;107:101-107.
36. Xiao S, McCarthy JG, Aster JC, et al. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain. Blood. 2000;96:699-704.
37. Dong S, Kang S, Gu T-L, et al. 14-3-3 integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198- FGFR1-transformed hematopoietic cells. Blood. 2007;110:360-369.
38. Chen J, DeAngelo DJ, Kutok JL, et al. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci USA. 2004; 101:14479-14484.
39. Roumiantsev S, Krause DS, Neumann CA, et al. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell. 2004;5:287-298.
40. Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer. 2005;5: 172-183.